Rating History for Quince Therapeutics Inc. (QNCX) by Lucid Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/30/2026 | Elemer Piros | Downgrade | Sell (Buy) |
N/A (8.00) |
0.27 (0.95) |
251.85% | Details |
 |
|||||||
